Ban pushed on OTC sale of weight loss meds to minors

NEWS BRIEFS

Ban pushed on OTC sale of weight loss meds to minors

/ 05:36 AM November 13, 2024

Ban pushed on OTC sale of weight loss meds to minors

Inquirer stock photo

MANILA, Philippines — A Cotabato lawmaker is pushing for a ban on the over-the-counter (OTC) sale of weight loss medicine and supplements to minors.

House Assistant Majority Leader Ma. Alana Samantha Santos has filed House Bill No. 11001 that imposes on violators fines ranging from P50,000 to P200,000 as well as the possible revocation of their license to operate.

Article continues after this advertisement

READ: Drug used in diabetes treatment helped dieters shed 60 pounds

FEATURED STORIES

Santos cited a 2024 systematic global review, which found that one in 10 adolescents has been using weight loss products that were not medically approved.

“Young Filipinos are especially susceptible to trying out cosmetic weight loss with the increasing exposure and influence of social media,” she said.

Article continues after this advertisement

Under HB 11001, those “operating a place of business where over-the-counter weight loss supplements are sold or offered for sale is prohibited from selling such products to individuals under 18 years of age.”

It also tasks the Department of Health to work with the Food and Drugs Administration to craft the implementing guidelines. — Jeannette I. Andrade

Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our daily newsletter

By providing an email address. I agree to the and acknowledge that I have read the .

opinion
business
www
business
business
TAGS: House bill, weight loss drugs

Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our newsletter!

By providing an email address. I agree to the and acknowledge that I have read the .

© Copyright 1997-2024 | All Rights Reserved

This is an information message

We use cookies to enhance your experience. By continuing, you agree to our use of cookies.